Bone Biologics Corporation

NASDAQ (USD): Bone Biologics Corporation (BBLGW)

Last Price

30.50

Today's Change

+3.60 (13.38%)

Day's Change

29.00 - 30.50

Trading Volume

1,518

Overview

Market Cap

2 Million

Shares Outstanding

76,733

Avg Volume

104

Avg Price (50 Days)

30.03

Avg Price (200 Days)

40.84

PE Ratio

-211.81

EPS

-0.14

Earnings Announcement

31-Mar-2023

Previous Close

26.90

Open

30.50

Day's Range

30.5 - 30.5

Year Range

2.87 - 70.44

Trading Volume

1,518

Price Change Highlight

1 Day Change

13.38%

5 Day Change

9.71%

1 Month Change

9.71%

3 Month Change

-49.59%

6 Month Change

-56.70%

Ytd Change

672.15%

1 Year Change

771.43%

3 Year Change

57.62%

5 Year Change

-14.57%

10 Year Change

-14.57%

Max Change

-14.57%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment